Anakinra versus treatment as usual in the treatment of acute gout

Registry ID

EUCTR2015-000696-27

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

prof. dr. M.A.F.J. van de Laar

Start date

2015-06-12

Completion date

2019-03-08

Last update

2026-08-16

Conditions

• Gout

Summary

The primary aim of this research is to demonstrate the noninferiority of anakinra compared with the standard of care in the treatment of acute gout flares.

Locations

• , , Netherlands

Related clinical trials

• A Study of Dotinurad Versus Allopurinol in Participants With Gout
• A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
• A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)
• Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration
• The Remote Monitoring of Gout Feasibility Study in Primary Care
• the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More

View on source registry